Vita 34 AG Logo

Vita 34 AG

ISIN: DE000A0BL849 | Ticker: V3V | LEI: 529900OEWA4GSZEZ4P40
Sector: Health Care – Sub-Industry: Health Care Services
Country: Germany
Website Investor Relations

About Vita 34 AG

Company Description

Vita 34 was founded in Leipzig in 1997 and is today one of the leading cell banks in Europe. As the first private umbilical cord blood bank in Europe and a pioneer in cell banking, the company has since then been a complete provider of cryopreservation services for the collection, processing and storage of stem cells from umbilical cord blood and umbilical cord tissue.
Based on the expansion of the business model in 2019, Vita 34 intends to also offer the storage of immune cells from peripheral blood as well as of stem cells from endogenous fat in the future. Endogenous cells are a valuable source of medical cell therapy and are kept alive at temperatures as low as minus 200 degrees Celsius to be used as part of a treatment when needed.

Year founded

1997

Served area

Europe

Headcount

120

Headquarters

Deutscher Platz 5a, 4103 Leipzig – Germany

Filings & Publications

2021
2020
2019
2018
2022

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
GER / ENG
GER / ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
GER / ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2019

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
ENG / GER
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2018

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG
ENG
Corporate Governance Report
Company Presentation
GER
GER
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
28.09.22 Dr. Granderath, Rat und Vermögen GmbH Close relation Buy EUR 21,557.28
02.06.22 Dr. Granderath, Rat und Vermögen GmbH Close relation Buy EUR 33,000.00
02.06.22 Schweppe, Thomas Supervisory board Other EUR 0.00
18.11.21 Lorenzen, Hans-Jochen Supervisory board Sell EUR 180,625.00
10.11.21 Project Mill Gesellschaft für interdisziplinären Know-how-Transfer GmbH Close relation Other EUR 36,146.25
09.11.21 Zeitfracht GmbH & Co. KGaA Close relation Sell EUR 35,525.00
09.11.21 von Blücher, Dietmar Board Buy EUR 28,820.00
09.11.21 von Blücher, Dietmar Board Buy EUR 14,400.00
09.11.21 von Blücher, Dietmar Board Buy EUR 7,898.00
09.11.21 Weng, Rüdiger K. Board Sell EUR 30.00

Capital markets information

ISIN

DE000A0BL849

LEI

529900OEWA4GSZEZ4P40

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Services

Designated Sponsor

Hauck Aufhäuser Lampe Privatbank AG

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.